Bayer Drug Patent Portfolio
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|
Bayer's Family Patents
Clinical Trials
Recent Clinical Trials by Bayer:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| Relative Bioavailability Study in Healthy Subjects Comparing 2 Dry Powder Oral Suspensions of Rivaroxaban Under Fasting and 20 mg of an Oral Suspension of Rivaroxaban Under Fed Conditions to 10 mg of an Immediate Release Tablet Under Fasting Conditions | Bayer | Janssen Research & Development, LLC |
COMPLETED
(Jun, 2015)
| PHASE1 |
Bayer Drug List
Given below is the complete list of Bayer's drugs and the patents protecting them.
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List